English | Español

American Academy Of Neurology
Sam Jackson | Apr 25, 2023

Teriflunomide study shows promise in delaying first symptoms of MS using medication as an 'early intervention'
Sam Jackson | Apr 25, 2023

New drug shows promise in preventing migraines for patients unresponsive to other treatments: 'These results are exciting'

Press release submission | May 2, 2019

AMERICAN ACADEMY OF NEUROLOGY: Cannabis-based Medicine May Reduce Seizures for Children with Difficult-to-Treat Epilepsy
Robert Hadley | May 16, 2017

Immunosuppressive drug cladribine may slow progression of MS

Ruth de Jauregui | May 7, 2017

Data from multiple sclerosis medication study shows promise
Robert Hadley | May 3, 2017

Clinical trial results offer hope for multiple sclerosis sufferers
Amanda Rupp | May 22, 2016

New ALS research announced at annual conference
Amanda Rupp | Apr 21, 2016

ALS Association announces new research fellowships

Trending
Patient Daily | Aug 1, 2025

Executive director of ASAP 340B: ‘The second largest drug discount program in the country doesn't have basic transparency’
Patient Daily | Aug 4, 2025

Founder of ReKlaim Health on 340B: ‘They pocket the difference, bill insurers and patients full price and call it charity care’
+ Pharmaceuticals
Patient Daily | Aug 5, 2025

American Lung Association study urges schools to prioritize clean classroom air
Patient Daily | Aug 7, 2025

Dallas Breathe Free Sinus & Allergy Centers earns 4.8-star rating from 670 Google reviews